Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab and ABVD for Hodgkin's Patients
- Status
- COMPLETED
- Phase
- PHASE2
MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
- Status
- TERMINATED
- Phase
- NA
Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
- Status
- UNKNOWN
- Phase
- PHASE2
Exercise Program for Adolescents and Young Adults With Cancer
- Status
- COMPLETED
- Phase
- NA
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE3
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
- Status
- WITHDRAWN
- Phase
- NA
G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients
- Status
- COMPLETED
- Phase
- PHASE2
Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan
- Status
- COMPLETED
- Phase
- PHASE2
Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Study of Bexxar in Relapsed/Refractory DLCL
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Epidemiology of Lymphoma Patients
- Status
- WITHDRAWN
- Phase
- N/A
Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1